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Abstract
There are a number of bacterial, viral, and parasitic diseases present at the Wildlife/
livestock/human interface. Brucellosis is a zoonotic disease of importance and highly
prevalent in sub-Saharan Africa. The important Brucella species at the wildlife/live‐
stock/human interface are Brucella arbortus, Brucella suis, and Brucella melitensis. These
species have been isolated from humans, livestock (cattle and goats), and wildlife (Af‐
rican buffalo and giraffe). A lot of studies indicated that density, herd size, age of cow,
reduced veterinary services like vaccination programs, and geographical area are as‐
sociated with Brucella prevalence. Studies in developing countries have indicated that
the disease is more prominent in the both commercial and communal farming sectors.
Access and consumption of contaminated foods and/or occupational exposure remain
the significant source of infection to humans. The pathogen transmission of brucello‐
sis is bidirectional in nature; hence, for control efforts to be successful, cooperation is
required between livestock owners, animal health officials, and wildlife managers.
Globally, trend is moving toward focusing on “one health,” which recognizes that hu‐
man, animal (both domestic and wild), and ecosystems are tightly linked. The suc‐
cessful management of disease requires an integrated approach where efforts are
focused in concert across these domains. Climate change, increased human popula‐
tions, and increased interaction at wildlife/livestock/human interface have resulted in
the change of brucellosis dynamics.
Keywords: Brucellosis, wildlife/livestock/human interface, emerging diseases, zoonot‐
ic diseases, surveillance, disease management
1. Introduction
Interest in the epidemiology of emerging diseases of humans and livestock as they relate to
wildlife has increased greatly over the past several decades [1]. The importance of wildlife in
the emergence of livestock and human brucellosis is due to multiple changes occurring within
wildlife, livestock, and human populations [1]. The epidemiology of infections and diseases
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is highly dependent on several factors within, or in the interfaces between, human, livestock,
or wildlife populations. Land use changes being speared by humans, which include encroach‐
ment into wildlife habitat, continue to increase, along with more intensified livestock produc‐
tion practices. This scenario is favorable to the spread of brucellosis. The alteration of wildlife
population demographics bring in a new dimension in the epidemiology of brucellosis, e.g.,
increasing African buffalo population in Southern Africa, which in turn increases the chances
of potential for contact and Brucella species transmission at the wildlife/livestock interface.
Figure 1. Map of proposed TFCAs in Africa.
Human and animal health populations are pivotal and important for economic development,
prosperity, and stability. Infectious diseases like brucellosis affect health and reproductivity
of livestock, thereby greatly reducing its value and opportunities for trade. Brucellosis is a
zoonosis and a disease of veterinary and public health significance worldwide. It is a disease
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that infects multiple species even in marine ecosystem, and it is also found in many continents.
The incidences and prevalence of the disease vary widely from country to country. Brucellosis
prevalence is relatively high in Africa, Latin American, and Asian countries. It is the disease
of sexually matured animals with predilection for placentas, fetal fluids, and testes of male
animals (OIE 2014). It is caused by bacteria of the genus Brucella. In sub-Saharan Africa, the
bacterium Brucella abortus has been identified in several free-ranging wildlife species. Brucel‐
la antibodies have been detected in various wildlife species, including waterbuck (Kobus
ellipsiprymnus), African buffalo (Syncerus caffer), eland (Taurotragus oryx), giraffe (Giraffa
camelopardalis), and impala (Aepyceros melampus) in Zimbabwe and South Africa. The impor‐
tance of brucellosis is reflected by its widespread distribution and impact on multiple animal
species, including cattle, sheep, goats, and pigs [2]. The livestock sector is dominated by
ruminants, and they are prone to brucellosis. This makes the disease economically important.
Interface spaces allow people, livestock, and wildlife to share space and resources in semi-arid
landscapes, especially transfrontier conservation areas (TFCAs) in Africa (see Figure 1). The
coexistence of domestic herbivores and wild animals has its advantages and disadvantages,
for example, ecotourism, but one of the major consequences is the risk of pathogen transmis‐
sion. The risk at the interface threatens local livelihoods depending on animal production,
ecotourism, public health in the case of brucellosis, national economies in the context of
transboundary animal diseases, and the success of integrated conservation and development
initiatives [3]. Globally, the role of wildlife in livestock diseases is expected to increase [4] in
conjunction with human population growth, which is expected to reach 9 billion by 2030.
Increased demand for animal protein will further increase potentially infectious contacts
between livestock and wildlife, leading to an increased potential for zoonotic diseases
(brucellosis) to emerge. The changes in the dynamics will result in challenges that will require
an improved understanding of the ecology of pathogens at the wildlife/livestock/human
interface along with the development of tools and mitigations to manage these pathogens.
2. Brucella species associated with the interface
The members of the genus Brucella are aerobic bacteria that multiply within macrophages and
cause infections in animals and humans [5]. The most relevant species from an economical and
public health perspective are B. abortus, B. suis, and B. melitensis. The three Brucella species are
the ones prevalent at the interfaces. The major cause of bovine brucellosis is B. abortus; however,
B. suis or B. melitensis have been occasionally implicated in some cattle herds. The following
species have been currently recognized: B. abortus (8 biovars), B. melitensis (3 biovars), B. suis
(5 biovars), B. ovis, B. canis, B. neotomae [6], B. pinnipedialis [7], B. ceti [7], B. microti [8], and B.
inopinata (wound fluid from human) [9, 10]. Little research has been done with regard to B.
canis and B. ovis as far as their dynamics and importance at the wildlife/livestock/human
interface. The traditional and current classification of Brucella species is largely based on its
preferred host, pathogenicity, and phenotypic laboratory tests (biotyping) [11]. Bovine
brucellosis is caused by B. abortus (8 biovars), which principally affects cattle and other
Bovidae, e.g., African buffalo and grater kudu. B. abortus biovar (bv.) 1 is the most frequently
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isolated biotype worldwide and the major cause of brucellosis in cattle. Mainly B. abortus bv
1 has been isolated from aborted fetuses and milk from cattle [12] and to a lesser extent B.
abortus bv 2 in commercial and communal farms in Zimbabwe [12].
B. melitensis (3 biovars) affects goats but can also infect sheep and cattle. B. melitensis has a
global distribution but does not occur in North America, Australia, and New Zealand. Apart
from affecting goats and sheep, it also affects camels (Camelus dromedarius), alpacas (Vicugna
pacos), and llamas (Lama glama) [13]. B. melitensis is rarely reported in wildlife with a few cases
reported in Europe in chamois and ibex in the Alps [13]. This is an area that needs more research
since very few studies have been done on the seroprevalence of brucellosis in wild ungulates,
which share interface with domestic animals.
The causative agent of brucellosis in swine, hares (Lepus), reindeer (Rangifer tarandus), and
other no primary hosts like dogs, horses, humans, and cattle is B. suis [6]. B. suis is currently
divided into 5 biovars. Biovars 1–3 infect Suidae of which bv. 1 and 3 may cause severe disease
in humans and require high biosafety laboratory precautions. B. suis bv. 4 infects reindeers
and caribous (R. tarandus) throughout the Arctic region and can be transmitted to cattle,
Canidae, and occasionally to humans [13], whereas B. suis bv. 5 has been reported from rodents.
B. abortus and B. suis have also been isolated worldwide from variety of wildlife species,
namely, African buffalo, eland, wild boar (Sus scrofa), and water buck [13]. In South American
countries, B suis biovar 1 has become established in cattle, and in some areas, cattle are now
more important than pigs as source of human infections. In sub-Saharan TFCAs, little work
has been done on brucellosis in wild pigs and warthogs. Information is not available on the
dynamics of the epidemiology of brucellosis in a scenario where wild pigs and warthogs are
infected with B. suis and interact with other wildlife especially other bovines.
3. Epidemiology of brucellosis at the interface
Areas with high population density result in increased infections in humans, while transmis‐
sion from livestock to humans is more likely in areas with high human and herd/farm density,
especially where humans and livestock live in close proximity, as is often the case in developing
countries [1]. The discovery of strains in marine animals has increased the complexity of
interactions between humans and other animals due to the fact that each type of species
discovered has distinctive epidemiological features. This overall affects the epidemiology of
brucellosis. The epidemiology of brucellosis is influenced by several factors, such as livestock
production type, herd size, interaction with wildlife, ecological, and socioeconomic factors
[14]. A lot of work done indicated that density, herd size, age of cow, reduced veterinary
services like vaccination programs, and geographical area are associated with high Brucella
prevalence. Seroprevalence studies in developing countries indicated that the disease is more
prominent in the commercial than communal farming sector. In cases where commercial farms
share an interface with wildlife, there is usually physical barrier to separate cattle and wildlife.
In cases of communal farms, there is usually no physical barrier and animals share grazing
space, thereby facilitating the transmission of Brucella pathogens. The dissemination of Brucella
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can be by direct or indirect contact with infectious animals. The major source of exposure to
B. abortus is the infected cattle. Sheep and goats are mainly infected by B. melitensis through
aborted fetuses, placenta, and post abortion uterine fluid. Brucella infection is principally
transmitted through contact with fetal membranes, lochia, post parturient discharges, and milk
[15]. Milk and vaginal secretions represent important potential routes of animal-to-animal
transmission following close contact. Venereal transmissions of brucellosis are common in
swine, ovine, and canines (dogs). Most of the Brucella organisms are shed by animals in their
blood at the early stages of the infection.
Access and consumption of contaminated foods and/or occupational exposure remains the
significant source of infection to humans. Infection occurs through the skin (intact or abraded),
inhalation, or conjunctiva. The main source of infection for the public is through the ingestion
of contaminated dairy product, especially raw milk, in developing countries. The bacteria can
also be transmitted in raw or undercooked meat from infected animals. This factor poses a
greater threat at TFCAs since communities have access to game meat through illegal means,
e.g., poaching. Abortion and infertility are the predominant clinical signs in ruminants [16]
B. suis typically causes chronic inflammatory lesions in the reproductive organs of susceptible
animals that may extend to joints and other organs. The most prominent clinical sign is abortion
at any stage of gestation [17]. B. suis biovar 1 infections have been reported in cattle but have
partial induced pathology and no induction of abortion despite the excretion of organisms in
the milk [13]. Evidence indicates the transmission of B. suis biovar 1 to cattle by feral swine in
USA [18]. B. suis infection in wild boars is of widespread occurrence but with a generally low
prevalence, while in domestic pigs, it is considered as a reemerging disease in some countries
as a consequence of spillover from wild boars to outdoor-reared pigs.
Studies in the mid-1990s found Brucella antibodies in sera of Zimbabwean wildlife in national
parks, hunting areas, and game ranches collected in 2009–2011. In most of the wildlife studies,
African buffalo is found to have the highest seroprevalence, followed by eland, and impala
had the lowest seroprevalence. Studies by Gomo et al. (2011) established low prevalence in
giraffe. Studies in the United States of America found out that of the 86 avian, ruminant, swine,
poultry, and lagomorph diseases that are reportable to the World Organization for Animal
Health (OIE), 53 are present in the United States; 42 (79%) of these have a putative wildlife
component associated with the transmission, maintenance, or life cycle of the pathogen; and
21 (40%) are known to be zoonotic [1]. Brucellosis has a wildlife reservoir that is a recognized
impediment to eradication in domestic populations [1]. A recent example of effects of changes
of the ecology at the interface is the transmission and introduction of bovine brucellosis from
livestock to native wood bison (Bison bison athabascae) populations in Canada, which has
created a conservation challenge for the species. Another well-publicized example is the
introduction of brucellosis into native bison and elk populations of the Yellowstone ecosystem
in 1917 [19]. This resulted in a wildlife management challenge due to conflicts between
livestock and bison. Spillover events from livestock into wildlife impact conservation of species
of concern. Transmission between livestock and wildlife is more likely to occur if the animal
population density is high and if livestock and wildlife are allowed to come into contact, as in
free-range systems. Characterization of the environmental conditions associated with disease
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and disease outbreaks is an important part to the understanding for the epidemiology of
brucellosis in wildlife. A very good example will be that of bison. They calve with other herd
members in close proximity, and calving events attract the attention of other cows and calves,
with licking and sniffing of the fetal membranes and neonate around parturition. This behavior
is especially marked early in the calving season and diminishes later after most animals have
calved. This behavior has contributed significantly in the spread of brucellosis in bison
populations and explains the maintenance host role of bison. In the elk, it is a different scenario
because they usually calve in seclusion, consume the placenta, and clean the calves soon after
birth. Elks keep the calf isolated from the herd for several days or weeks following parturition.
This behavior explains the absence of brucellosis in most elk populations in North America [1].
4. Brucellosis in human at the interface
About 58% of the infectious diseases of humans are estimated to be zoonoses,  and they
comprise almost three-quarters of emerging infectious diseases [1].  Brucellosis is directly
and indirectly transmitted from animals to humans.  Human-to-human transmissions are
rare, and small ruminants are the main reservoir for human cases. Humans can be infected
directly  by  contact  with  the  conjunctival  or  oronasal  mucosae  of  infected  animals,  or
indirectly by the ingestion of contaminated animal products (mainly dairy products) [16].
Naturally  acquired  brucellosis  in  humans  almost  always  comes  from  the  animal  reser‐
voirs, although very few cases of human to human transmission have been reported [11].
Brucellosis is considered an occupational disease of adults, but there are now several reports
of childhood brucellosis in literature [20]. Human brucellosis is predominantly an occupa‐
tional  disease;  professions  in  direct  contact  with livestock (farmers,  butchers,  veterinari‐
ans, laboratory personnel, etc.) are those at higher risk. In humans, both acute and chronic
forms of the disease with variable clinical manifestations were found. Disease can occur at
any age and affect any organ system [21].
Low reporting figures and lack of resources have resulted in the global incidence of human
brucellosis not being accurately recorded. Hence, great variations exist between different
geographic areas even within the same country. Although the reported incidence in most
developed countries where infection is present is generally smaller than 1 case per 100,000
inhabitants, in endemic areas, such as some Arab countries, reports reach up to 200 cases per
100,000 inhabitants. However, because of the deficiencies in health services of many countries
where brucellosis is endemic, there are no reliable data on the global status of the human
disease [16].This is one of the reasons why exact impact of human brucellosis at the interface
is not known. At present, there is no fully reliable method of preventing human brucellosis.
To safeguard people, attention has been directed toward effectively controlling the disease in
animals especially at wildlife/livestock/human interface. Sheep and goats are the main
reservoirs of infection for humans; in some countries, bovines, buffalos, yaks (Bos grunniens),
and camels can also be implicated. Unfortunately, there is a lack of knowledge on the alter‐
natives for controlling B melitensis infection in these species. Globally, there is growing
recognition that more integrated determinants of health approach will be required to make
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further gains in managing wildlife diseases like brucellosis, especially those at the wildlife,
human, and domestic animal interface [22]. Brucella has been isolated from milk and blood
(indicating that some animals are bacteremic). It is crucial that public awareness should be
strengthened to reduce the risk of human exposure to Brucella infection.
5. Preventions and control of brucellosis at the interface
The control of brucellosis shared with wildlife requires the development of strategies that will
reduce pathogen transmission between wildlife, both domestic animals and human beings. B.
abortus is adapted to cattle as its primary host, and control strategies have focused on elimi‐
nation of the disease from cattle populations. Best available methods to control brucellosis
include comprehensive surveillance before and after import testing [23]. The control of
brucellosis is usually based on vaccination, serology testing, and culling. These methods are
not very successful at the interface due to the complexity of interactions and cost involved.
Most framers in developing countries cannot afford the test and slaughter policy in cattle, and
the situation will be far worse if it involves wildlife. The eradication of brucellosis in livestock
is an expensive and a labor- and diagnostic-intensive process. One of the reasons why many
countries have failed to successively eradicate brucellosis is poor animal health management
conditions/programs. Brucellosis control strategies in developed and developing countries are
based on calf hood vaccination with the S19 vaccine, test, and slaughter techniques. In countries
like Zimbabwe, vaccination with S19 was compulsory for commercial herds and optional in
the communal areas since the 1980s [14], and this strategy managed to reduce prevalence of
brucellosis in cattle. Bovine brucellosis has been successfully eradicated in many developed
countries after significant investment and many years of vaccinating and culling. A figure of
500,000 new cases per year is usually accepted as a global estimate [16]. There is a substantial
economic burden of brucellosis reflected by the costs of attaining and maintaining disease free
status, or the cost of disease in terms of loss of productivity and control costs [24]
In order to improve and succeed, governments need to improve on the quality of the national
veterinary services and administrative organizations involved. The prevention and control of
brucellosis in sub-Saharan Africa is hampered by low veterinary coverage and use of outdated
diagnostic techniques [25]. Furthermore, clinical diagnosis is complicated by variable incuba‐
tion periods. Testing of livestock is cumbersome when dealing with farms located in remote
areas or with animals from nomadic populations and migratory farmers. The identification of
genus, species of field isolates, and molecular epidemiology of strains will benefit brucellosis
eradication programs [18] since correct vaccination and control management will be possible.
Many countries have implemented eradication programs resulting in the reduction or
elimination of the disease, but the disease remains enzootic in many regions of the world. In
those countries where the disease has been eradicated or strictly controlled, continued
surveillance is essential to preventing the reemergence of the disease. Microbial genome typing
or DNA fingerprinting is important for the delineation of outbreaks of infectious diseases and
for the universal tracing of virulent or multi resistant pathogens [26]. It is now of paramount
importance to determine by epidemiological trace-back analysis where the infection originat‐
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ed, how it was spread, and what measures are needed to prevent additional spread of the
disease from this primary source. The information will be vital at the interface since it will
confirm the source of pathogen; hence, control and prevention efforts will be targeted at source.
Knowledge of the spread and prevalence of the infection is essential when planning control
measures.
It is generally recognized that the prevention of human brucellosis is best achieved by the
control or eradication of the disease in animals, but this strategy is not relevant for protection
against a bioterrorist attack on military or civilian populations. A human vaccine could
possibly be an effective countermeasure for prevention of naturally occurring or deliberately
induced human infections [23]. Currently, three vaccine strains (B. abortus S19 and RB51 and
B. melitensis Rev1) are recommended by the World Organization for Animal Health (Office
International des Epizooties [OIE]) for use in the control of brucellosis in livestock [27]. It is
generally acknowledged that all of the available brucellosis vaccines are only effective in
specific hosts, and cross-protection is not readily achieved [23]. At present, no effective vaccine
is available for the protection of swine from brucellosis [28]. The vaccination of sheep is by
smooth B. melitensis Rev1 vaccine, but it does not provide 100% protection, and it interferes
with common serological test use in sheep (rose bengal test (RBT) and complement fixation
test (CFT). B. melitensis Rev1 is one of the most commonly used attenuated live vaccines against
caprine brucellosis and induces high level of protection in goat. Rev1 vaccine has suffered from
a lack of coordinated standardization in production methods, leading to considerable varia‐
bility in efficiency of different preparations [29], and carries resistance to streptomycin, an
antibiotic that is therapeutically useful in man. Despite the availability of two smooth live
vaccine strains, B. abortus S19 for cattle and B. melitensis Rev1 for small ruminants, and a further
rough attenuated strain, B. abortus RB51 for cattle, the search for improved vaccines and vaccine
for human continues. Vaccination now has only a small role in the prevention of human
disease. B. abortus strain 19 still appears to be as effective as the method of prevention of B.
abortus infection in cattle. The RB51 strain of B. abortus, an R mutant used as a live vaccine, has
been licensed in some countries, for example, the United States of America. RB51 does not
interfere with diagnostic serologic tests, and during laboratory trials, efficacy appeared well
compared with that of strain 19 [68]. Currently, rfb mutants of B. melitensis and B. suis are under
development for the prevention of ovine/caprine and porcine brucellosis. The current vaccine
strains can cause abortion when administered to pregnant animals, and they are virulent.
Currently, they are no vaccines for pigs and wildlife and no satisfactory vaccines against
human brucellosis.
The control of brucellosis at wildlife/livestock/human interface requires improved collabora‐
tion between public health and veterinary services; this can be enhanced through the rein‐
forcement or the establishment of national zoonoses committees, in which the relevant
producer and consumer organizations should be also represented. As long as the national
veterinary service organization is adequate, the prevalence of disease and economic resources
will dictate the approach. Test- and slaughter-based programs are often unfeasible in devel‐
oping countries because of the economic cost. In addition, countries that have successfully
eradicated B melitensis offer monetary compensation to affected shepherds, which are not
Updates on Brucellosis40
possible in poor resource developing countries. When veterinary service organizations,
farmers’ involvement, and economic resources are adequate, the final technical elements to
select a proper strategy should be the prevalence of disease and the definition of the minimal
epidemiologic unit(s) of intervention. A survey should identify the percentage of infected
flocks/herds, understanding that differences in prevalence would be expected between
different regions placed in the same epidemiologic unit of intervention. Calculating mean
prevalence figures for the whole country or particular region considered is a frequent error of
decision makers, as those figures may not reflect local conditions. Taking generalist sanitary
measures will result in failure of brucellosis control and eradication, but decision makers
should apply different strategies adequate to each of the different epidemiologic situations
identified. The minimal epidemiologic unit of intervention should be a given territorial
extension with similar epidemiologic situation. In some cases, this can be a couple of isolated
flocks/herds in a village and in others, the whole flocks/herds of a given county, but frequently,
all flocks/herds in a region or country. The implementation of any brucellosis sanitary
strategies requires considerable technical training and an awareness campaign aimed at the
farmers and general population. Once all these elements have been properly defined, two
possible alternatives exist to fight B melitensis infection in small ruminants: [1] control based
on mass (whole flock/herd) vaccination or [2] eradication based on test and slaughter with or
without vaccination. In both cases, the use of adequate vaccination procedures and diagnostic
tests is of paramount importance.
Successful disease control may be dependent on accurate detection in wildlife reservoirs,
including African buffalo (S. caffer). Nishi et al. (2006) stated that it was important to under‐
stand the ecologic, socioeconomic, and political factors that affect the wildlife–human–
agriculture interface. It is equally important to having technically sound information when
developing management plans for disease control. For the sake of public, livestock, and
wildlife health, a holistic approach beyond conventional human and veterinary medicine must
be taken. This approach must include ecosystem health as well as social/cultural aspects. The
success of disease control in wildlife depends on many factors, including disease ecology,
natural history, and the characteristics of the pathogen, the availability of suitable diagnostic
tools, the characteristics of the domestic and wildlife host(s) and vectors, the geographical
spread of the problem, the scale of the control effort, and the attitude of stakeholders. The
successful management or eradication of these diseases will require the development of cross-
discipline and institutional collaborations. The complex nature of these systems highlights the
need to understand the role of wildlife in the epidemiology, transmission, and maintenance
of infectious diseases of livestock [1]. Despite social and policy challenges, there remain
opportunities to develop new collaborations and new technologies to mitigate the risks posed
at the wildlife/livestock interface.[1]. The need to develop comprehensive surveillance systems
that integrate livestock, wildlife, and human components has been suggested. Robust surveil‐
lance systems in wildlife and at the livestock–wildlife interface to provide early detection of
brucellosis or spill over and spillback of pathogens between livestock and wildlife is essential.
Diseases that arise from the wildlife/livestock interface are of paramount importance and must
be an area of focus for animal health authorities [4].There are many barriers in preventing,
detecting, monitoring, and managing brucellosis. These may include political and legal
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hurdles, lack of knowledge about brucellosis of wildlife, absence of basic data on wildlife
populations, difficulties with surveillance, and logistical constraints. Once a pathogen is
identified at the wildlife/livestock interface, active management and control of the disease
agent is often the only method for reducing impacts to human health, agriculture, and
recreational hunting industries [30].
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